Promising News: Sanders Plans October Nomination Hearing for NIH Candidate

Sen. Bernie Sanders (I-Vt.) sets October confirmation hearing for Monica Bertagnolli, the Biden administration’s nominee for National Institutes of Health (NIH) leader, aiming to alleviate drug pricing concerns. The announcement, made on Friday, brings an end to the administration’s months-long standoff with Sanders. Sanders previously declared his opposition to any health agency nominee until the …

Read more

Generic Drug Giants Settle Price-Fixing Charges with DOJ

Two leading generic drug companies have reached settlements with the Department of Justice (DOJ) regarding charges of criminal price fixing. The U.S. division of Teva, based in Israel, will pay a $225 million criminal penalty over five years, while the U.S. division of Glenmark, based in India, will pay a $30 million criminal penalty. Both …

Read more

Bipartisan Bill to Enhance Oversight of Pharmacy Benefit Managers Introduced by Carper and Grassley

Senators Tom Carper of Delaware and Chuck Grassley of Iowa have introduced a new bill, the PBM Oversight Act of 2023, aimed at granting the Centers for Medicare and Medicaid Services (CMS) greater authority in regulating pharmacy benefit managers (PBMs) and their influence on drug pricing. PBMs act as intermediaries within the pharmaceutical industry, negotiating …

Read more

PhRMA Files Lawsuit Against Biden Administration on Medicare Drug Price Negotiations

The largest lobbying group in the pharmaceutical industry, the Pharmaceutical Research and Manufacturers of America (PhRMA), has filed a lawsuit challenging certain provisions in the Biden administration’s Inflation Reduction Act. These provisions allow Medicare to negotiate prices for specific drugs. The lawsuit, filed in the U.S. District Court for the Western District of Texas, argues …

Read more

Lawsuit Filed by Chamber of Commerce Against Biden Administration on Federal Control of Drug Prices

The U.S. Chamber of Commerce has filed a lawsuit against the Biden administration over the Medicare price negotiation provisions in the Inflation Reduction Act. Merck also filed a lawsuit earlier this week, making the Chamber of Commerce the second organization to challenge the measure. In a statement, the Chamber of Commerce argued that government price …

Read more